Modeling familial alzheimer's disease with induced pluripotent stem cells

Takuya Yagi, Daisuke Ito, Yohei Okada, Wado Akamatsu, Yoshihiro Nihei, Hideyuki Okano, Norihiro Suzuki

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is the most common form of age-related dementia, characterized by progressive memory loss and cognitive disturbance. According to the amyloid cascade hypothesis, a prevailing theory of AD pathology, accumulation of toxic Aβ42, in the brain is the initiator of AD pathogenesis, subsequently leading to the formation of neurofibrillary tangles, and consequently neuronal loss. Mutations of presenilin 1 (PS1) and presenilin 2(PS2), which are catalytic components of γ-secretase, are causative factors for autosomal dominant early-onset familial AD (FAD). Induced pluripotent stem cell (iPSC) technology provides a new method for elucidating the molecular basis of human diseases, including neurodegenerative diseases. Here we generate iPSCs from fibroblasts of FAD patients with mutations in PS1 (A246E) and PS2 (N141I), and characterize the differentiation of these cells into neurons. We find that FAD-iPSC-derived differentiated neurons have increased toxic Aβ42 secretion, recapitulating the molecular pathogenesis of mutant presenilins. Furthermore, secretion of Aβ42 from these neurons sharply responds to γ secretase inhibitors and modulators, indicating the potential for identification and validation of candidate drugs. Our findings demonstrate that the FAD-iPSC-derived neuron is a valid model of AD and provides an innovative strategy for the study of late-onset neurodegenerative diseases.

Original languageEnglish
Pages (from-to)1134-1136
Number of pages3
JournalClinical Neurology
Volume52
Issue number11
DOIs
Publication statusPublished - 2012

Fingerprint

Induced Pluripotent Stem Cells
Alzheimer Disease
Presenilin-2
Presenilin-1
Neurons
Amyloid Precursor Protein Secretases
Poisons
Neurodegenerative Diseases
Presenilins
Mutation
Neurofibrillary Tangles
Memory Disorders
Amyloid
Dementia
Cell Differentiation
Fibroblasts
Pathology
Technology
Brain
Pharmaceutical Preparations

Keywords

  • Alzheimer's disease
  • IPSC

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Okano, H., & Suzuki, N. (2012). Modeling familial alzheimer's disease with induced pluripotent stem cells. Clinical Neurology, 52(11), 1134-1136. https://doi.org/10.5692/clinicalneurol.52.1134

Modeling familial alzheimer's disease with induced pluripotent stem cells. / Yagi, Takuya; Ito, Daisuke; Okada, Yohei; Akamatsu, Wado; Nihei, Yoshihiro; Okano, Hideyuki; Suzuki, Norihiro.

In: Clinical Neurology, Vol. 52, No. 11, 2012, p. 1134-1136.

Research output: Contribution to journalArticle

Yagi, T, Ito, D, Okada, Y, Akamatsu, W, Nihei, Y, Okano, H & Suzuki, N 2012, 'Modeling familial alzheimer's disease with induced pluripotent stem cells', Clinical Neurology, vol. 52, no. 11, pp. 1134-1136. https://doi.org/10.5692/clinicalneurol.52.1134
Yagi, Takuya ; Ito, Daisuke ; Okada, Yohei ; Akamatsu, Wado ; Nihei, Yoshihiro ; Okano, Hideyuki ; Suzuki, Norihiro. / Modeling familial alzheimer's disease with induced pluripotent stem cells. In: Clinical Neurology. 2012 ; Vol. 52, No. 11. pp. 1134-1136.
@article{7d94d099b2ca4c76b2635e7f1e67d7fc,
title = "Modeling familial alzheimer's disease with induced pluripotent stem cells",
abstract = "Alzheimer's disease (AD) is the most common form of age-related dementia, characterized by progressive memory loss and cognitive disturbance. According to the amyloid cascade hypothesis, a prevailing theory of AD pathology, accumulation of toxic Aβ42, in the brain is the initiator of AD pathogenesis, subsequently leading to the formation of neurofibrillary tangles, and consequently neuronal loss. Mutations of presenilin 1 (PS1) and presenilin 2(PS2), which are catalytic components of γ-secretase, are causative factors for autosomal dominant early-onset familial AD (FAD). Induced pluripotent stem cell (iPSC) technology provides a new method for elucidating the molecular basis of human diseases, including neurodegenerative diseases. Here we generate iPSCs from fibroblasts of FAD patients with mutations in PS1 (A246E) and PS2 (N141I), and characterize the differentiation of these cells into neurons. We find that FAD-iPSC-derived differentiated neurons have increased toxic Aβ42 secretion, recapitulating the molecular pathogenesis of mutant presenilins. Furthermore, secretion of Aβ42 from these neurons sharply responds to γ secretase inhibitors and modulators, indicating the potential for identification and validation of candidate drugs. Our findings demonstrate that the FAD-iPSC-derived neuron is a valid model of AD and provides an innovative strategy for the study of late-onset neurodegenerative diseases.",
keywords = "Aβ, Alzheimer's disease, IPSC",
author = "Takuya Yagi and Daisuke Ito and Yohei Okada and Wado Akamatsu and Yoshihiro Nihei and Hideyuki Okano and Norihiro Suzuki",
year = "2012",
doi = "10.5692/clinicalneurol.52.1134",
language = "English",
volume = "52",
pages = "1134--1136",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "11",

}

TY - JOUR

T1 - Modeling familial alzheimer's disease with induced pluripotent stem cells

AU - Yagi, Takuya

AU - Ito, Daisuke

AU - Okada, Yohei

AU - Akamatsu, Wado

AU - Nihei, Yoshihiro

AU - Okano, Hideyuki

AU - Suzuki, Norihiro

PY - 2012

Y1 - 2012

N2 - Alzheimer's disease (AD) is the most common form of age-related dementia, characterized by progressive memory loss and cognitive disturbance. According to the amyloid cascade hypothesis, a prevailing theory of AD pathology, accumulation of toxic Aβ42, in the brain is the initiator of AD pathogenesis, subsequently leading to the formation of neurofibrillary tangles, and consequently neuronal loss. Mutations of presenilin 1 (PS1) and presenilin 2(PS2), which are catalytic components of γ-secretase, are causative factors for autosomal dominant early-onset familial AD (FAD). Induced pluripotent stem cell (iPSC) technology provides a new method for elucidating the molecular basis of human diseases, including neurodegenerative diseases. Here we generate iPSCs from fibroblasts of FAD patients with mutations in PS1 (A246E) and PS2 (N141I), and characterize the differentiation of these cells into neurons. We find that FAD-iPSC-derived differentiated neurons have increased toxic Aβ42 secretion, recapitulating the molecular pathogenesis of mutant presenilins. Furthermore, secretion of Aβ42 from these neurons sharply responds to γ secretase inhibitors and modulators, indicating the potential for identification and validation of candidate drugs. Our findings demonstrate that the FAD-iPSC-derived neuron is a valid model of AD and provides an innovative strategy for the study of late-onset neurodegenerative diseases.

AB - Alzheimer's disease (AD) is the most common form of age-related dementia, characterized by progressive memory loss and cognitive disturbance. According to the amyloid cascade hypothesis, a prevailing theory of AD pathology, accumulation of toxic Aβ42, in the brain is the initiator of AD pathogenesis, subsequently leading to the formation of neurofibrillary tangles, and consequently neuronal loss. Mutations of presenilin 1 (PS1) and presenilin 2(PS2), which are catalytic components of γ-secretase, are causative factors for autosomal dominant early-onset familial AD (FAD). Induced pluripotent stem cell (iPSC) technology provides a new method for elucidating the molecular basis of human diseases, including neurodegenerative diseases. Here we generate iPSCs from fibroblasts of FAD patients with mutations in PS1 (A246E) and PS2 (N141I), and characterize the differentiation of these cells into neurons. We find that FAD-iPSC-derived differentiated neurons have increased toxic Aβ42 secretion, recapitulating the molecular pathogenesis of mutant presenilins. Furthermore, secretion of Aβ42 from these neurons sharply responds to γ secretase inhibitors and modulators, indicating the potential for identification and validation of candidate drugs. Our findings demonstrate that the FAD-iPSC-derived neuron is a valid model of AD and provides an innovative strategy for the study of late-onset neurodegenerative diseases.

KW - Aβ

KW - Alzheimer's disease

KW - IPSC

UR - http://www.scopus.com/inward/record.url?scp=84880554107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880554107&partnerID=8YFLogxK

U2 - 10.5692/clinicalneurol.52.1134

DO - 10.5692/clinicalneurol.52.1134

M3 - Article

C2 - 23196540

AN - SCOPUS:84880554107

VL - 52

SP - 1134

EP - 1136

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 11

ER -